These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 22179996)
1. Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis. Yuan H; Niu YM; Wang RX; Li HZ; Chen N Genet Mol Res; 2011 Nov; 10(4):3356-64. PubMed ID: 22179996 [TBL] [Abstract][Full Text] [Related]
2. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects. Qiu LX; Yao L; Zhang J; Zhu XD; Zhao XM; Xue K; Mao C; Chen B; Zhan P; Yuan H; Hu XC Breast Cancer Res Treat; 2010 Nov; 124(1):229-35. PubMed ID: 20204500 [TBL] [Abstract][Full Text] [Related]
3. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies. Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049 [TBL] [Abstract][Full Text] [Related]
4. Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects. Lin H; Lin D; Zheng C Diagn Pathol; 2014 Jan; 9():15. PubMed ID: 24443924 [TBL] [Abstract][Full Text] [Related]
5. Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies. Zhang Y; Ding D; Wang X; Zhu Z; Huang M; He X Int J Colorectal Dis; 2011 Oct; 26(10):1257-64. PubMed ID: 21541661 [TBL] [Abstract][Full Text] [Related]
6. XPD Lys751Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis. Cui J; Li D; Shen L; Zhang W; Xu X Tumour Biol; 2014 Jul; 35(7):6335-41. PubMed ID: 24652592 [TBL] [Abstract][Full Text] [Related]
7. Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis. Peng Q; Li S; Lao X; Chen Z; Li R; Qin X Medicine (Baltimore); 2014 Dec; 93(29):e330. PubMed ID: 25546681 [TBL] [Abstract][Full Text] [Related]
8. XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies. Ding DP; Ma WL; He XF; Zhang Y Mol Biol Rep; 2012 Mar; 39(3):2533-40. PubMed ID: 21667112 [TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer. Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991 [TBL] [Abstract][Full Text] [Related]
10. XPD polymorphisms, cigarette smoking, and bladder cancer risk: a meta-analysis. Wang M; Gu D; Zhang Z; Zhou J; Zhang Z J Toxicol Environ Health A; 2009; 72(11-12):698-705. PubMed ID: 19492231 [TBL] [Abstract][Full Text] [Related]
11. [DNA repair gene xeroderma pigmentosum group D 751 polymorphism and the risk on esophageal cancer: a meta-analysis]. Wu XB; Dai LP; Wang YP; Wang KJ; Zhang JY Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):281-5. PubMed ID: 19642387 [TBL] [Abstract][Full Text] [Related]
12. XPD Lys751Gln polymorphisms and the risk of esophageal cancer: an updated meta-analysis. Guo XF; Wang J; Lei XF; Zeng YP; Dong WG Intern Med; 2015; 54(3):251-9. PubMed ID: 25748732 [TBL] [Abstract][Full Text] [Related]
13. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Stern MC; Johnson LR; Bell DA; Taylor JA Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500 [TBL] [Abstract][Full Text] [Related]
14. XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies. Yin QH; Liu C; Hu JB; Meng RR; Li L; Wang YJ Asian Pac J Cancer Prev; 2013; 14(1):231-6. PubMed ID: 23534729 [TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions. McCarty KM; Smith TJ; Zhou W; Gonzalez E; Quamruzzaman Q; Rahman M; Mahiuddin G; Ryan L; Su L; Christiani DC Carcinogenesis; 2007 Aug; 28(8):1697-702. PubMed ID: 17470448 [TBL] [Abstract][Full Text] [Related]
16. XPD Lys751Gln and Asp312Asn polymorphisms and susceptibility to skin cancer: a meta-analysis of 17 case-control studies. Zhu HL; Bao JM; Lin PX; Li WX; Zou ZN; Huang YE; Chen Q; Shen H Asian Pac J Cancer Prev; 2014; 15(16):6619-25. PubMed ID: 25169498 [TBL] [Abstract][Full Text] [Related]
17. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk. Liu G; Zhou W; Yeap BY; Su L; Wain JC; Poneros JM; Nishioka NS; Lynch TJ; Christiani DC Carcinogenesis; 2007 Jun; 28(6):1254-8. PubMed ID: 17264068 [TBL] [Abstract][Full Text] [Related]
18. XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk. Stern MC; Siegmund KD; Conti DV; Corral R; Haile RW Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2384-90. PubMed ID: 17164360 [TBL] [Abstract][Full Text] [Related]
19. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma. Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510 [TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis. Ma Q; Qi C; Tie C; Guo Z Gene; 2013 Nov; 530(2):309-14. PubMed ID: 23973729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]